New treatment option for Oral Anxiolytic
Official title Anxiety and Surgery Satisfaction for Cataract Patient With Different State Anxiety
ClinicalTrials.gov ID: NCT06826417
What this study is testing
What is Xanax?
Xanax is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for oral anxiolytic.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study aims to explore the effects of anxiety traits on pain, anxiety, and anesthesia satisfaction in patients undergoing cataract surgery under topical anesthesia. On the day of recruitment, patients will complete the BAI, STAI-S, and STAI-T anxiety questionnaires to assess baseline anxiety levels.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80. Healthy volunteers may be eligible.
You may be able to join if
- Age between 18 and 80 years old.
- Patients diagnosed with cataracts.
- Scheduled for cataract surgery with phacoemulsification and intraocular lens implantation under surface anesthesia at National Taiwan University...
- No adverse reactions to oral anti-anxiety medication (XANAX).
You likely can't join if
- Presence of any contraindications for surgery before the procedure.
- Presence of any contraindications for medication before the procedure.
- Inability to provide clear and complete answers to relevant questionnaires, or expression of no preoperative anxiety during the outpatient visit, or...
- Regular use of anti-anxiety medications, sleeping pills, or analgesics before the procedure.
- Pregnancy or breastfeeding during the preoperative period.
- Severe corneal diseases, overripe cataracts, small pupils, or lens dislocation leading to difficulties in conventional surgery.
See the full eligibility criteria
- Age between 18 and 80 years old.
- Patients diagnosed with cataracts.
- Scheduled for cataract surgery with phacoemulsification and intraocular lens implantation under surface anesthesia at National Taiwan University Hospital.
- No adverse reactions to oral anti-anxiety medication (XANAX).
- Presence of any contraindications for surgery before the procedure.
- Presence of any contraindications for medication before the procedure.
- Inability to provide clear and complete answers to relevant questionnaires, or expression of no preoperative anxiety during the outpatient visit, or scores below 21 on the STAI-S or STAI-T assessment.
- Regular use of anti-anxiety medications, sleeping pills, or analgesics before the procedure.
- Pregnancy or breastfeeding during the preoperative period.
- Severe corneal diseases, overripe cataracts, small pupils, or lens dislocation leading to difficulties in conventional surgery.
- Patients under surface anesthesia who cannot fully cooperate with the surgical procedure.
- Pregnant or uncertain pregnancy status (women under 55 years old to be verbally asked by research team members).
The study team makes the final eligibility decision.
Where it's taking place
- Taipei, Taiwan, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Taipei, Taiwan, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.